168 related articles for article (PubMed ID: 37073715)
1. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.
Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B
Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715
[TBL] [Abstract][Full Text] [Related]
2. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
3. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of immune-related genes in laryngeal squamous cell carcinoma.
Liu W; Zhang C; Gong X; Liao W; Xu J; Zhang X
Transl Cancer Res; 2020 Oct; 9(10):6287-6302. PubMed ID: 35117238
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X
Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L
Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747
[TBL] [Abstract][Full Text] [Related]
9. Smoking patients with laryngeal cancer screened with a novel immunogenomics-based prognostic signature.
Shen Y; Zhou H; Dong S; Dong W; Zhang L
Front Genet; 2022; 13():961764. PubMed ID: 35910213
[TBL] [Abstract][Full Text] [Related]
10. Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma.
Fu D; Zhang B; Yang L; Huang S; Xin W
Front Genet; 2020; 11():978. PubMed ID: 33005178
[TBL] [Abstract][Full Text] [Related]
11. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma.
She Y; Kong X; Ge Y; Yin P; Liu Z; Chen J; Gao F; Fang S
Cancer Cell Int; 2020; 20():22. PubMed ID: 31988638
[TBL] [Abstract][Full Text] [Related]
12. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses.
Zhu Q; Zhang R; Lu F; Zhang X; Zhang D; Zhang Y; Chen E; Han F; Zha D
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15185-15206. PubMed ID: 37639011
[TBL] [Abstract][Full Text] [Related]
15. Construction of a novel MPT-driven necrosis-related lncRNAs signature for prognosis prediction in laryngeal squamous cell carcinoma.
Liu J; Zhang M; Sun Q; Qin X; Gao T; Xu Y; Han S; Zhang Y; Guo Z
Environ Sci Pollut Res Int; 2023 Jul; 30(31):77210-77225. PubMed ID: 37249774
[TBL] [Abstract][Full Text] [Related]
16. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
17. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients.
Zhou S; Meng Q; Wang Z
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4451-4460. PubMed ID: 35478043
[TBL] [Abstract][Full Text] [Related]
19. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
20. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.
Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C
J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
